Delving into the Latest Updates on PBI-1402 with Synapse

Overview

Basic Info

Drug Type

Small molecule drug

Synonyms

PBI 1402

Target

GM-CSF

Mechanism

GM-CSF stimulants(Macrophage colony stimulating factor 2 stimulants), Erythropoiesis stimulants(Erythropoiesis stimulants)

Therapeutic Areas

Hemic and Lymphatic DiseasesUrogenital Diseases

Active Indication-

Inactive Indication

AnemiaKidney Diseases

Originator Organization

Liminal BioSciences, Inc.

Active Organization-

Inactive Organization

Shanghai Allist Pharmaceuticals Co., Ltd.

Liminal BioSciences, Inc.

Drug Highest PhasePendingPhase 2

First Approval Date-

Regulation-

(-)-Epigallocatechin gallate, (-)-Gossypol; Ad.hIFN-beta, AF-37702, Agatolimod sodium, Agomelatine, Alvocidib hydrochloride, ARC-1779; Belimumab, BIBW-2992, Binodenoson, Bortezomib, Bosutinib, Brivaracetam; Cediranib, Clevidipine, CNTO-328, CP-751871, Curcumin; Darapladib, Deforolimus, Denosumab, Desvenlafaxine succinate, Dipyridamole/prednisolone, Dronedarone hydrochloride, DTPw-HBV/Hib 2.5; Ecogramostim, Elacytarabine, Eltrombopag, Eprodisate sodium; Farnesylthiosalicylic acid, Febuxostat, Fenretinide, Ferumoxytol, FMP2.1/AS02A, Forodesine hydrochloride, FP-0011; HuLuc-63, Human Fibroblast Growth Factor 1; Idraparinux sodium, Indium 111 (111In) ibritumomab tiuxetan, Interleukin-21, Ipilimumab, ISS-1018, ITF-2357; Lapaquistat acetate, Laropiprant, Liposomal vincristine, LY-518674; Masitinib mesylate, MAXY-G34, MGCD-0103, Midostaurin, Mitumprotimut-T, MK-0343, MLN-1202, MM-093, Motexafin gadolinium; NB-001, NB-002, Niacin/laropiprant; Oblimersen sodium, Ocrelizumab, Omacetaxine mepesuccinate; Panobinostat, Patupilone, PBI-1402, Perifosine, PHA-739358, Plerixafor hydrochloride, Prasugrel; Regadenoson, RHAMM R3 peptide, Rilonacept, Rivaroxaban, Romiplostim; Safinamide mesilate, Salinosporamide A, Selenite sodium, Sotrastaurin; Thrombin alfa, Tipifarnib, TRO-19622; Vatalanib succinate, Vernakalant hydrochloride, VRC-WNVDNA017-00-VP; YM-155, Yttrium 90 (90Y) ibritumomab tiuxetan; Zosuquidar trihydrochloride.

100 Deals associated with PBI-1402

Login to view more data

External Link

KEGG	Wiki	ATC	Drug Bank
-	-	-	DB05480

R&D Status

10 top R&D records.

Login

to view more data

Indication	Highest Phase	Country/Location	Organization	Date
Anemia	Phase 2	CN	Shanghai Allist Pharmaceuticals Co., Ltd.	19 Oct 2010
Anemia	Phase 2	CA	Liminal BioSciences, Inc.	19 Oct 2010
Kidney Diseases	IND Approval	CA	Liminal BioSciences, Inc.	11 Jan 2007